Non-Hodgkin Lymphoma | Tumor

CURE’s non-Hodgkin lymphoma (NHL) page is an extensive resource of cancer information featuring the latest NHL news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on non-Hodgkin lymphoma.

Brukinsa Receives FDA Approval for Treatment of Waldenstrom’s Macroglobulinemia

September 1st 2021, 10:29pm

Article

The FDA approval of Brukinsa, according to an expert from the Dana-Farber Cancer Institute, provides an important new option for targeted therapy in Waldenstrom’s macroglobulinemia.

Survivor Turns Negative Thoughts Into Laughable Moments During Cancer Treatment

August 6th 2021, 1:00pm

Video

A survivor shares how she chose to approach her mindset during cancer treatments to keep herself from spiraling.

Roundup Herbicide Will Ditch Glyphosate, the Chemical Linked to Cancer

July 29th 2021, 11:00pm

Article

Bayer, the manufacturer of Roundup, created a five-point plan to decrease the risk of facing future litigation about its product causing cancer.

Patients With Blood Cancer Less Likely to Produce COVID-19 Antibodies After Vaccination

July 26th 2021, 1:00pm

Article

About 25% of patients with blood cancer did not produce antibodies after being vaccinated against COVID-19.

Pistol Annies’ Singer Ashley Monroe Shares Cancer Diagnosis, Cancer Survivor Breaks Weightlifting Records, And More

July 16th 2021, 3:00pm

Article

From Ashley Monroe’s blood cancer diagnosis to a CrossFit athlete’s inspiring cancer journey, here’s what’s happening in the cancer landscape this week.

How Do You Get Back to a ‘Normal Life’ After Cancer?

July 9th 2021, 11:00pm

Video

Do you keep your job? Your friends? One cancer survivor discusses her decisions after being told her non-Hodgkin lymphoma was in remission.

Turning Chemotherapy Into Comedy

July 8th 2021, 3:00pm

Podcast

In this episode of the “CURE® Talks Cancer” podcast, a cancer survivor explains how she took a lighthearted and comedic approach to her cancer treatment process and went on to create a coloring book based on the funny thoughts she had.

Novel Combo Therapy Shows Promise in Certain Patients With Non-Hodgkin Lymphoma

June 6th 2021, 5:00pm

Article

Treatment with a novel combination therapy was associated with increased efficacy among patients with aggressive relapsed or refractory B-cell non-Hodgkin lymphoma and was also well tolerated.

FDA Approves Xalkori for Children, Young Adults With Relapsed or Refractory Anaplastic Large Cell Lymphoma

January 14th 2021, 10:49pm

Article

The Food and Drug Administration approved the supplemental new drug application for Xalkori (crizotinib) to treat children and young adults between the ages of 1 and 21 with relapsed or refractory, systemic ALK-positive anaplastic large cell lymphoma.

CAR-T Cell Therapy Product for Relapsed/Refractory Large B-Cell Lymphoma Still Under FDA Review

January 6th 2021, 10:00pm

Article

The FDA has not yet reached a decision on an application for the approval of a CAR-T cell therapy product for the treatment of relapsed/refractory large b-cell lymphoma and, according to Bristol Myers Squibb, a new action date for the decision has not been set.